Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy.

Saved in:
Bibliographic Details
Title: Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy.
Authors: Chong, Elise A.1 elise.chong@pennmedicine.upenn.edu, Ruella, Marco1, Schuster, Stephen J.1, Lymphoma Program Investigators at the University of Pennsylvania (CORPORATE AUTHOR)
Source: New England Journal of Medicine. 2/18/2021, Vol. 384 Issue 7, p673-674. 2p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMc2030164